Legend Biotech (LEGN) is scheduled to report Q4 earnings on March 10, 2026. Analysts estimate EPS of $-0.18 and quarterly revenue of $306.03M.
In the most recent quarter (Q3), Legend Biotech reported EPS of $-0.05, beating estimates of $-0.12 by 0.58%. Revenue came in at $272.33M, missing the estimate of $276.00M by 0.01%.
Over the last 4 quarters, Legend Biotech has averaged an EPS surprise of 0.62% and a revenue surprise of 0.05%.
Analyze the earnings history of Legend Biotech using advanced sorting and filters.
The chart below shows Legend Biotech's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Legend Biotech's reported revenue compared to analyst estimates over recent quarters.
Legend Biotech (LEGN) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
The Actual EPS was $-0.05, which beat the estimate of $-0.12.
The Actual Revenue was $272.33M, which missed the estimate of $276.00M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-0.05 | $-0.12 | 58.3 % |
| Q2 | 2025-08-11 | $-0.34 | $-0.21 | -61.9 % |
| Q1 | 2025-05-13 | $-0.07 | $-0.25 | 72.0 % |
| Q4 | 2025-03-11 | $-0.15 | $-0.33 | 54.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $272.33M | $276.00M | -1.33 % |
| Q2 | 2025-08-11 | $255.06M | $227.58M | 12.1 % |
| Q1 | 2025-05-13 | $195.05M | $193.88M | 0.61 % |
| Q4 | 2025-03-11 | $186.52M | $178.93M | 4.24 % |